These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 7976026)

  • 1. Thiol dependent inhibition of mouse leukemia L1210 DNA topoisomerase I by nitracrine.
    Ciesielska E; Szmigiero L
    Acta Biochim Pol; 1994; 41(2):141-3. PubMed ID: 7976026
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of mammalian topoisomerase I by 1-nitro-9-aminoacridines. Dependence on thiol activation.
    Ciesielska E; Pastwa E; Szmigiero L
    Acta Biochim Pol; 1997; 44(4):775-80. PubMed ID: 9584859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The intercalative DNA binding and antitumor activity of some bis-acridines related to nitracrine.
    Acheson RM; Taylor GN; Waring MJ; Haylock S; Abel G
    Chem Biol Interact; 1985 May; 53(3):371-5. PubMed ID: 4006013
    [No Abstract]   [Full Text] [Related]  

  • 4. Interactions of some nitro-derivatives of substituted 9-aminoacridine with DNA.
    Filipski J; Marczyński B; Sadzińska L; Chalupka G; Chorazy M
    Biochim Biophys Acta; 1977 Sep; 478(1):33-43. PubMed ID: 196646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of inhibition of DNA-dependent RNA synthesis in vitro by Ledakrin.
    Gniazdowski M
    Mater Med Pol; 1978; 10(3):159-65. PubMed ID: 723289
    [No Abstract]   [Full Text] [Related]  

  • 6. Crosslinking of cellular DNA by nitracrine and furocoumarin derivatives.
    Studzian K; Tołwińska-Stańczyk Z; Wilmańska D; Palumbo M; Gniazdowski M
    Neoplasma; 1999; 46(1):50-3. PubMed ID: 10355534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitracrine and its congeners--an overview.
    Gniazdowski M; Szmigiero L
    Gen Pharmacol; 1995 May; 26(3):473-81. PubMed ID: 7789719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Properties of a purified nuclear topoisomerase from L1210 cells.
    Ross CF; Brougham MJ; Holloman WK; Ross WE
    Biochim Biophys Acta; 1983 Nov; 741(2):230-6. PubMed ID: 6317036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of G(2) arrest enhances cell death induced by the antitumor 1-nitroacridine derivative, Nitracrine.
    Skladanowski A
    Apoptosis; 2002 Aug; 7(4):347-59. PubMed ID: 12101394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disulfiram is a potent in vitro inhibitor of DNA topoisomerases.
    Yakisich JS; Sidén A; Eneroth P; Cruz M
    Biochem Biophys Res Commun; 2001 Nov; 289(2):586-90. PubMed ID: 11716515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of the poly (ADP-ribose) polymerase (PARP) inhibitor NU1025 on topoisomerase I and II inhibitor cytotoxicity in L1210 cells in vitro.
    Bowman KJ; Newell DR; Calvert AH; Curtin NJ
    Br J Cancer; 2001 Jan; 84(1):106-12. PubMed ID: 11139322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure of acridines and their effect on RNA synthesis in vitro.
    Szmigiero L; Slaska K; Ciesielska E; Jaros-Kamińska B; Gniazdowski M
    Acta Biochim Pol; 1977; 24(1):35-44. PubMed ID: 868436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual topoisomerase I and II inhibition by intoplicine (RP-60475), a new antitumor agent in early clinical trials.
    Poddevin B; Riou JF; Lavelle F; Pommier Y
    Mol Pharmacol; 1993 Oct; 44(4):767-74. PubMed ID: 8232227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the anticancer drug oracin on mouse liver topoisomerases I and II.
    Stuchlík S; Turna J; Miko M
    J Pharm Pharmacol; 2005 May; 57(5):657-9. PubMed ID: 15901355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topoisomerase I activities in L-1210 cell nuclei.
    Filipski J; Yin J; Kohn KW
    Enzyme; 1983; 30(2):89-94. PubMed ID: 6311533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Modulation of the antitumor activity of 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosoure a by O(6)-methyl-2'-deoxyguanosine--a new inhibitor of O(6)-alkylguanine-DNA-alkyltransferase].
    Dederer LIu; Sokolova IS; Bakhmedova AA; Miniker TD; Mel'nik SIa; Gorbacheva LB
    Biokhimiia; 1995 Sep; 60(9):1521-9. PubMed ID: 8562657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Syntheses and biological activities (topoisomerase inhibition and antitumor and antimicrobial properties) of rebeccamycin analogues bearing modified sugar moieties and substituted on the imide nitrogen with a methyl group.
    Anizon F; Belin L; Moreau P; Sancelme M; Voldoire A; Prudhomme M; Ollier M; Sevère D; Riou JF; Bailly C; Fabbro D; Meyer T
    J Med Chem; 1997 Oct; 40(21):3456-65. PubMed ID: 9341921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxic mechanism of XK469: resistance of topoisomerase IIbeta knockout cells and inhibition of topoisomerase I.
    Snapka RM; Gao H; Grabowski DR; Brill D; Chan KK; Li L; Li GC; Ganapathi R
    Biochem Biophys Res Commun; 2001 Feb; 280(4):1155-60. PubMed ID: 11162648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo growth of mouse leukemia L1210 cells with metabolic alterations in the subunits of ribonucleotide reductase.
    Somerville L; Cory AH; Cory JG
    In Vivo; 2002; 16(3):175-7. PubMed ID: 12182112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intermittent exposure of medulloblastoma cells to topotecan produces growth inhibition equivalent to continuous exposure.
    Danks MK; Pawlik CA; Whipple DO; Wolverton JS
    Clin Cancer Res; 1997 Oct; 3(10):1731-8. PubMed ID: 9815557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.